FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1873477530> ?p ?o ?g. }

• W1873477530 endingPage "27238" @default.
• W1873477530 startingPage "27227" @default.
• W1873477530 abstract "// Larisa Venkova 1, 2 , Alexander Aliper 1, 3 , Maria Suntsova 1, 2, 3 , Roman Kholodenko 4 , Denis Shepelin 1, 4 , Nicolas Borisov 1, 2 , Galina Malakhova 4 , Raif Vasilov 5 , Sergey Roumiantsev 3, 6, 7 , Alex Zhavoronkov 3, 8 , Anton Buzdin 3, 4, 5 1 Drug Research and Design Department, Pathway Pharmaceuticals, Wan Chai, Hong Kong, Hong Kong SAR 2 Department of Personalized Medicine, First Oncology Research and Advisory Center, Moscow, Russia 3 Laboratory of Bioinformatics, D. Rogachyov Federal Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia 4 Group for Genomic Regulation of Cell Signaling Systems, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia 5 National Research Centre “Kurchatov Institute”, Centre for Convergence of Nano-, Bio-, Information and Cognitive Sciences and Technologies, Moscow, Russia 6 Pirogov Russian National Research Medical University, Department of Oncology, Hematology and Radiotherapy, Moscow, Russia 7 Moscow Institute of Physics and Technology, Department of Translational and Regenerative Medicine, Dolgoprudny, Moscow Region, Russia 8 Insilico Medicine, Inc, ETC, Johns Hopkins University, Baltimore, MD, USA Correspondence to: Anton Buzdin, e-mail: buzdin@ponkc.com Keywords: anticancer target drugs, cancer, signaling pathway, metabolic pathway, gene expression Received: January 17, 2015      Accepted: July 17, 2015      Published: July 30, 2015 ABSTRACT Effective choice of anticancer drugs is important problem of modern medicine. We developed a method termed OncoFinder for the analysis of new type of biomarkers reflecting activation of intracellular signaling and metabolic molecular pathways. These biomarkers may be linked with the sensitivity to anticancer drugs. In this study, we compared the experimental data obtained in our laboratory and in the Genomics of Drug Sensitivity in Cancer (GDS) project for testing response to anticancer drugs and transcriptomes of various human cell lines. The microarray-based profiling of transcriptomes was performed for the cell lines before the addition of drugs to the medium, and experimental growth inhibition curves were built for each drug, featuring characteristic IC 50 values. We assayed here four target drugs - Pazopanib, Sorafenib, Sunitinib and Temsirolimus, and 238 different cell lines, of which 11 were profiled in our laboratory and 227 - in GDS project. Using the OncoFinder-processed transcriptomic data on ~600 molecular pathways, we identified pathways showing significant correlation between pathway activation strength (PAS) and IC 50 values for these drugs. Correlations reflect relationships between response to drug and pathway activation features. We intersected the results and found molecular pathways significantly correlated in both our assay and GDS project. For most of these pathways, we generated molecular models of their interaction with known molecular target(s) of the respective drugs. For the first time, our study uncovered mechanisms underlying cancer cell response to drugs at the high-throughput molecular interactomic level." @default.
• W1873477530 created "2016-06-24" @default.
• W1873477530 creator A5002829891 @default.
• W1873477530 creator A5008472454 @default.
• W1873477530 creator A5011857086 @default.
• W1873477530 creator A5013472071 @default.
• W1873477530 creator A5036742375 @default.
• W1873477530 creator A5045818684 @default.
• W1873477530 creator A5056031629 @default.
• W1873477530 creator A5062609945 @default.
• W1873477530 creator A5074978501 @default.
• W1873477530 creator A5079640410 @default.
• W1873477530 creator A5086561075 @default.
• W1873477530 date "2015-07-30" @default.
• W1873477530 modified "2023-10-16" @default.
• W1873477530 title "Combinatorial high-throughput experimental and bioinformatic approach identifies molecular pathways linked with the sensitivity to anticancer target drugs" @default.
• W1873477530 cites W1511697598 @default.
• W1873477530 cites W1527265103 @default.
• W1873477530 cites W1629179716 @default.
• W1873477530 cites W1870892629 @default.
• W1873477530 cites W1883695122 @default.
• W1873477530 cites W1885723045 @default.
• W1873477530 cites W1901713749 @default.
• W1873477530 cites W1981972440 @default.
• W1873477530 cites W1982424532 @default.
• W1873477530 cites W1988303870 @default.
• W1873477530 cites W1989310302 @default.
• W1873477530 cites W1995533874 @default.
• W1873477530 cites W2013824261 @default.
• W1873477530 cites W2035788919 @default.
• W1873477530 cites W2050263735 @default.
• W1873477530 cites W2060647510 @default.
• W1873477530 cites W2085274379 @default.
• W1873477530 cites W2087312216 @default.
• W1873477530 cites W2091781842 @default.
• W1873477530 cites W2100651100 @default.
• W1873477530 cites W2108068107 @default.
• W1873477530 cites W2112046350 @default.
• W1873477530 cites W2114438891 @default.
• W1873477530 cites W2120468822 @default.
• W1873477530 cites W2122271737 @default.
• W1873477530 cites W2123303054 @default.
• W1873477530 cites W2126264325 @default.
• W1873477530 cites W2137874618 @default.
• W1873477530 cites W2142742274 @default.
• W1873477530 cites W2149107469 @default.
• W1873477530 cites W2167057573 @default.
• W1873477530 cites W3217677266 @default.
• W1873477530 doi "https://doi.org/10.18632/oncotarget.4507" @default.
• W1873477530 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4694985" @default.
• W1873477530 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26317900" @default.
• W1873477530 hasPublicationYear "2015" @default.
• W1873477530 type Work @default.
• W1873477530 sameAs 1873477530 @default.
• W1873477530 citedByCount "23" @default.
• W1873477530 countsByYear W18734775302016 @default.
• W1873477530 countsByYear W18734775302017 @default.
• W1873477530 countsByYear W18734775302018 @default.
• W1873477530 countsByYear W18734775302019 @default.
• W1873477530 countsByYear W18734775302020 @default.
• W1873477530 countsByYear W18734775302021 @default.
• W1873477530 countsByYear W18734775302023 @default.
• W1873477530 crossrefType "journal-article" @default.
• W1873477530 hasAuthorship W1873477530A5002829891 @default.
• W1873477530 hasAuthorship W1873477530A5008472454 @default.
• W1873477530 hasAuthorship W1873477530A5011857086 @default.
• W1873477530 hasAuthorship W1873477530A5013472071 @default.
• W1873477530 hasAuthorship W1873477530A5036742375 @default.
• W1873477530 hasAuthorship W1873477530A5045818684 @default.
• W1873477530 hasAuthorship W1873477530A5056031629 @default.
• W1873477530 hasAuthorship W1873477530A5062609945 @default.
• W1873477530 hasAuthorship W1873477530A5074978501 @default.
• W1873477530 hasAuthorship W1873477530A5079640410 @default.
• W1873477530 hasAuthorship W1873477530A5086561075 @default.
• W1873477530 hasBestOaLocation W18734775301 @default.
• W1873477530 hasConcept C126322002 @default.
• W1873477530 hasConcept C143998085 @default.
• W1873477530 hasConcept C161191863 @default.
• W1873477530 hasConcept C32220436 @default.
• W1873477530 hasConcept C41008148 @default.
• W1873477530 hasConcept C502942594 @default.
• W1873477530 hasConcept C60644358 @default.
• W1873477530 hasConcept C71924100 @default.
• W1873477530 hasConcept C86803240 @default.
• W1873477530 hasConceptScore W1873477530C126322002 @default.
• W1873477530 hasConceptScore W1873477530C143998085 @default.
• W1873477530 hasConceptScore W1873477530C161191863 @default.
• W1873477530 hasConceptScore W1873477530C32220436 @default.
• W1873477530 hasConceptScore W1873477530C41008148 @default.
• W1873477530 hasConceptScore W1873477530C502942594 @default.
• W1873477530 hasConceptScore W1873477530C60644358 @default.
• W1873477530 hasConceptScore W1873477530C71924100 @default.
• W1873477530 hasConceptScore W1873477530C86803240 @default.
• W1873477530 hasIssue "29" @default.
• W1873477530 hasLocation W18734775301 @default.
• W1873477530 hasLocation W18734775302 @default.
• W1873477530 hasLocation W18734775303 @default.
• W1873477530 hasLocation W18734775304 @default.

• next